News Conference News AHA 2017 ‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18 Michael O'Riordan November 15, 2017
News Conference News AHA 2017 GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS Yael L. Maxwell November 14, 2017
Presentation TCT 2017 Switching Between Oral P2Y12 Receptor Inhibitors: When and How? Presenter: Dominick J. Angiolillo, Marco Valgimigli, Matthew J. Price October 30, 2017
Presentation TCT 2017 Crushing and Chewing Oral P2Y12 Receptor Inhibitors: Pharmacodynamic and Clinical Impact Presenter: Dominick J. Angiolillo, Marco Valgimigli, Fabiana Rollini October 30, 2017
Presentation TCT 2017 Debate: Making the Case for Not Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors! Presenter: John A. Bittl, Freek W.A. Verheugt, Somjot S. Brar October 30, 2017
Presentation TCT 2017 Debate: Making the Case for Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors! Presenter: John A. Bittl, Freek W.A. Verheugt, Dimitrios Alexopoulos October 30, 2017
Presentation TCT 2017 Treatment of Coronary Bifurcations in the Contemporary Era of P2Y12 Inhibitors and "Biologically Active Stents" Presenter: Davide Capodanno, David Hildick-Smith, Marco Zimarino October 30, 2017
News Conference News TCT 2017 Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors Todd Neale October 30, 2017
News Daily News Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI Yael L. Maxwell October 03, 2017
News Daily News Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies L.A. McKeown September 25, 2017
News Daily News New Performance and Quality Metrics for STEMI and NSTEMI Care Michael O'Riordan September 21, 2017
News Daily News Extended Low-Dose Ticagrelor May Prevent Adverse Events Post-MI, Study Finds Yael L. Maxwell September 12, 2017
News Conference News ESC 2017 ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach Todd Neale September 01, 2017
News Conference News ESC 2017 Fentanyl, Ubiquitous in US Cath Labs, Blunts Antiplatelet Drugs in PCI Shelley Wood September 01, 2017
News Conference News ESC 2017 CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS Todd Neale August 30, 2017
News Conference News ESC 2017 P2Y12 Inhibitor Pretreatment Questioned in STEMI Todd Neale August 29, 2017
News Conference News ESC 2017 ESC Updates Guidelines for Treating STEMI Patients Michael O'Riordan August 27, 2017
News Conference News ESC 2017 Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART Shelley Wood August 27, 2017
News Conference News EuroPCR 2017 My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not Shelley Wood June 02, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2017 Shelley Wood June 01, 2017